Insights
Insights From Our Experts
Articles
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme “Shaping the Future…
Digital Therapeutics: A Necessity for Italy – Insights from Roberto Ascione and Alberta Spreafico
A Collaborative Approach to Integrating Digital Therapeutics (DTx) into the Italian Health System Roberto Ascione, our President, Health Innovation, and Alberta Spreafico, PhD, MBA, Senior Vice President, Health Innovation, have co-authored the Italian publication “Digital Therapeutics:…
Enhancing Patient Adherence and Sales Outcomes in Advanced Prostate Cancer Treatment Through Proactive Push Alerts
Data and analytics play a crucial role in developing patient adherence programs by providing actionable insights and enabling data-driven decision-making. Through our latest case study, see how this information was used to develop tailored push alerts…
The Evolving Landscape of HCP Engagement and the Role of Medical Information in This Era of Digital Innovation
This poster delves into the dynamic landscape of HCP engagement and the pivotal role of Medical Information (MI). It underscores the significance of effective HCP engagement for enhancing clinical decision-making and patient outcomes and emphasizes the…
Launching in the EU/U.K.: The 7-Step Countdown to Success
THE LAUNCH Eager to explore the vast potential of launching your product in the EU/UK? While the mission is challenging, thorough preparations can ensure a smooth route to success. You only get one chance to launch,…
RWEsearch 2024 | Innovating Clinical Trial Design with Real World Evidence
At the RWEsearch Annual Summit 2024, hosted by Healthark Insights, Chris Cameron, Chief Scientific Officer at EVERSANA, emphasized that advancements in Real World Evidence will accelerate with ongoing learning and use of technology and AI.
Enhancing Quality of Life in Advanced Breast Cancer: The Role of Palbociclib
Posted by
Alexandra Hall , Ngoc Nguyen , Meaghan Bartlett , Imtiaz Samjoo on September 18, 20249/18/24
Advanced breast cancer often comes with significant physical symptoms, such as pain and fatigue, as well as side effects from treatments. The diagnosis and treatment of advanced breast cancer can lead to anxiety, depression and stress.…
Preparing for Joint Clinical Assessments: How Early PICO Planning Ensures Smoother Submissions
Because the EU Health Technology Assessment (HTA) regulation will take effect in January 2025, pharmaceutical and medical device companies must prepare for a new era in health technology evaluations. The Joint Clinical Assessment (JCA), a core…
Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets
Are you interested in the latest developments in high-cost drug reforms across the EU4+UK markets? Our comprehensive paper, “Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets,” delves into the intricate landscape of pharmaceutical pricing and…
Tumor Types Drive Oncology Product Launch Strategies
Unlike traditional launch plans designed for blockbuster products, oncology and hematology therapy commercialization requires agility. Different tumor types and the form of therapy require distinct commercialization strategies. Patients with lung, breast, or colon cancer often undergo…